Oncology - European Medical Journal

Continue

Oncology

Filter
20 Oct 2022

Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer's Operating Systems

This symposium session presented at the ESMO 2022 included presentations exploring different and new aspects of treating patients.
Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine
15 Jun 2022

Management of patients with oncogene-driven NSCLC: the shift towards personalized medicine

Discuss the importance of the implementation of biomarker testing in routine clinical practice and the current and future challenges…
Navigating the Current Treatment Landscape in Esophageal Cancer with an Eye Toward the Future
15 Oct 2021

Navigating the Current Treatment Landscape in Esophageal Cancer with an Eye Toward the Future

Novartis sponsored ESMO 2021 Satellite Symposium: Navigating the Current Treatment Landscape Faculty: Prof Eric…
2 Apr 2020

Second AACR International Meeting: Advances in Malignant Lymphoma

Second AACR International Meeting: Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application held in…
29 Aug 2019

Comprehensive Genomic Profiling (CGP) Enabled by Next-Generation Sequencing Technology

CGP enabled by next-generation sequencing (NGS) technology allows all known biomarkers to be evaluated in a single test.
16 Nov 2018

ESMO 2018 - Congress Highlights

Catch up on this year’s European Society for European Society for Medical Oncology (ESMO) annual congress, with our inside look at the Internationales…
9 Feb 2018

Progress in the treatment of chronic lymphocytic leukaemia

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jeremy S. Abramson, MD, of the Massachusetts General Hospital Cancer Center…
9 Feb 2018

New trials for cancer patients at Sarah Cannon Research Institute

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute, UK…
We’ve noticed you’re accessing
from North/South America.